Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 48, 2024 - Issue 1
116
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Premarital Screening is Pivotal in Reducing the Births of Babies Affected with Thalassemia Major in Iraq

, , &
Pages 56-59 | Received 11 Aug 2023, Accepted 22 Feb 2024, Published online: 02 Apr 2024

References

  • Payandeh M, Rahimi Z, Zare ME, et al. The prevalence of anemia and hemoglobinopathies in the hematologic clinics of the Kermanshah Province, Western Iran. Int J Hematol Stem Cell Res. 2014;8(2):33–37.
  • Mandrile G, Barella S, Giambona A, et al. First and second level haemoglobinopathies diagnosis: best practices of the Italian society of thalassemia and haemoglobinopathies (SITE). J Clin Med. 2022;11(18):5426. doi: 10.3390/jcm11185426.
  • Hamamy HA, Al-Allawi NAS. Epidemiological profile of common haemoglobinopathies in Arab countries. J Community Genet. 2013;4(2):147–167. doi: 10.1007/s12687-012-0127-8.
  • Ghosh K, Colah R, Manglani M, et al. Guidelines for screening, diagnosis and management of hemoglobinopathies. Indian J Hum Genet. 2014;20(2):101–119. doi: 10.4103/0971-6866.142841.
  • Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704–712.
  • Al-Allawi NA, Al-Dousky AA. Frequency of haemoglobinopathies at premarital health screening in Dohuk, Iraq: implications for a regional prevention programme. East Mediterr Heal J. 2010;16(4):381–385.
  • Al-Allawi N, Al Allawi S, Jalal SD. Genetic epidemiology of hemoglobinopathies among Iraqi Kurds. J Community Genet. 2021;12(1):5–14. doi: 10.1007/s12687-020-00495-z.
  • Yahya HI, Khalel KJ, Al-Allawi NAS, et al. Thalassaemia genes in Baghdad, Iraq. East Mediterr Health J. 1996;2(2):315–319. doi: 10.26719/1996.2.2.315.
  • Al-Allawi NAS, Jalal SD, Ahmed NH, et al. The first five years of a preventive programme for haemoglobinopathies in Northeastern Iraq. J Med Screen. 2013;20(4):171–176. doi: 10.1177/0969141313508105.
  • Fm A, Fa A, Ms A, et al. The prevalence of sickle cell disease in Abu-AL-Khasib district of southern Iraq. J Trop Med Hyg. 1981;84(2):77–80.
  • Al-Allawi NAS, Jalal SD, Nerwey FF, et al. Sickle cell disease in the Kurdish population of northern Iraq. Hemoglobin. 2012;36(4):333–342. doi: 10.3109/03630269.2012.692344.
  • Tadmouri GO, Nair P, Obeid T, et al. Consanguinity and reproductive health among Arabs. Reprod Health. 2009;6(1):17. (doi: 10.1186/1742-4755-6-17.
  • Cousens NE, Gaff CL, Metcalfe SA, et al. Carrier screening for β-thalassaemia: a review of international practice. Eur J Hum Genet. 2010;18(10):1077–1083. doi: 10.1038/ejhg.2010.90.
  • Amato A, Giordano PC. Screening and genetic diagnosis of hemoglobinopathies in Southern and Northern Europe: two examples. Mediterr J Hematol Infect Dis. 2009;1(1):e2009007. doi: 10.4084/MJHID.2009.007.
  • World Health Organization Human Genetics Programme. Proposed international guidelines on ethical issues in medical genetics and genetic services (part I). Rev Derecho Genoma Hum. 1998;8(8):219–223.
  • Cowan RS. Moving up the slippery slope: mandated genetic screening on Cyprus. Am J Med Genet C Semin Med Genet. 2009;151C (1):95–103. doi: 10.1002/ajmg.c.30202.
  • Hassan MK, Taha JY, Al-Naama LM, et al. Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra. East Mediterr Health J. 2003;9(1-2):45–54. doi: 10.26719/2003.9.1-2.45.
  • Jalal SD, Al-Allawi NAS, Bayat N, et al. β-Thalassemia mutations in the Kurdish population of northeastern Iraq. Hemoglobin. 2010;34(5):469–476. doi: 10.3109/01676830.2010.513591.
  • Cavdar AO, Arcasoy A. The incidence of β-thalassemia and abnormal hemoglobins in Turkey. Acta Haematol. 1971;45(5):312–318. doi: 10.1159/000208641.
  • Nasiri A, Rahimi Z, Vaisi-Raygani A. Hemoglobinopathies in Iran: an updated review. Int J Hematol Stem Cell Res. 2020;14(2):140–150.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.